Core Insights - The latest net value of GF Healthcare Stock A (004851) is 2.0249 yuan, reflecting a decline of 1.32% [1] - The fund has shown a one-month return of 6.25%, a six-month return of 26.21%, and a year-to-date return of 25.27%, with respective rankings of 355 out of 656, 77 out of 637, and 148 out of 635 [1] Fund Holdings - The top ten holdings of GF Healthcare Stock A account for a total of 50.56%, with the largest positions being: - Zai Lab Ltd (9.36%) - Kelun Pharmaceutical (8.62%) - Baillie Gifford (7.47%) - XinNuoWei (4.61%) - Hansoh Pharmaceutical (4.45%) - WuXi AppTec (4.07%) - Dong-E E-Jiao (3.07%) - BeiGene Ltd (3.07%) - KAILI Medical (3.01%) - Huatai Medical (2.83%) [1] Fund Background - GF Healthcare Stock A was established on August 10, 2017, and as of June 30, 2025, it has a total scale of 5.247 billion yuan [1] - The fund manager is Wu Xingwu, who has extensive experience in the investment management field [2]
8月12日广发医疗保健股票A净值下跌1.32%，近1个月累计上涨6.25%
Sou Hu Cai Jing·2025-08-12 12:19